Thinking beyond HbA1c in type 2 diabetes - Tackling Cardiovascular Morbidity and Mortality – A focus on SGLT2 Inhibitors

The UKCPA/JOMO study day has become the main event in the respiratory pharmacy calendar. Despite the challenges this year this speakers and sessions were excellent.
NHS attendee at the UKCPA/JOMO respiratory study day
Satellite Thinking beyond HbA1c in type 2 diabetes - Tackling Cardiovascular Morbidity and Mortality – A focus on SGLT2 Inhibitors
Speakers Dr Rani Khatib, Consultant Pharmacist in Cardiology and Cardiovascular Research, Leeds Teaching Hospitals NHS Trust
Satellite Description

This session has been sponsored, including speaker honoraria and presentation development support, by the Boehringer Ingelheim and Lilly Diabetes Alliance

PC-GB-100225 September 2019

Back to Course

Website by MAXX Design

© 2020 Pharman | All rights reserved | Site Map | Accessibility | Privacy and Cookie Policy | Terms & Conditions

Confirmation

This site is intended for healthcare professionals or people employed in the pharmaceutical industry. Please confirm that you are such a person.

Continue